The Randomized CRM: An Approach to Overcoming the Long-Memory Property of the CRM

Joseph S. Koopmeiners, Andrew Wey

The primary object of a phase I clinical trial is to determine the maximum tolerated dose (MTD). Typically, the MTD is identified using a dose-escalation study, where initial subje…